Treatment of Secondary Infliximab Failure in Crohn's Disease Based on Serum Levels of Infliximab and Antibodies Against Infliximab: The Danish Study of Optimizing Infliximab Therapy in Crohn's Disease (Do It Crohn) Randomized Clinical Trial

Casper Steenholdt, Jorn Brynskov, Ole. Thomsen, Lars K. Munck, Jan Fallingborg, Lisbet A. Christensen, Gitte Pedersen, Jens Kjeldsen, Bent A. Jacobsen, Anne Sophie Oxholm, Jakob Kjellberg, Klaus Bendtzen, Mark A. Ainsworth

Research output: Contribution to journalConference abstract in journalResearchpeer-review

Original languageEnglish
Article number94
JournalGastroenterology
Volume144
Issue number5, Supplement 1
Pages (from-to)22
ISSN0016-5085
DOIs
Publication statusPublished - 2013

Cite this

Steenholdt, Casper ; Brynskov, Jorn ; Thomsen, Ole. ; Munck, Lars K. ; Fallingborg, Jan ; Christensen, Lisbet A. ; Pedersen, Gitte ; Kjeldsen, Jens ; Jacobsen, Bent A. ; Oxholm, Anne Sophie ; Kjellberg, Jakob ; Bendtzen, Klaus ; Ainsworth, Mark A. / Treatment of Secondary Infliximab Failure in Crohn's Disease Based on Serum Levels of Infliximab and Antibodies Against Infliximab : The Danish Study of Optimizing Infliximab Therapy in Crohn's Disease (Do It Crohn) Randomized Clinical Trial. In: Gastroenterology. 2013 ; Vol. 144, No. 5, Supplement 1. pp. 22 .
@article{f38a8c8297ae4162a367450e69299c37,
title = "Treatment of Secondary Infliximab Failure in Crohn's Disease Based on Serum Levels of Infliximab and Antibodies Against Infliximab: The Danish Study of Optimizing Infliximab Therapy in Crohn's Disease (Do It Crohn) Randomized Clinical Trial",
author = "Casper Steenholdt and Jorn Brynskov and Ole. Thomsen and Munck, {Lars K.} and Jan Fallingborg and Christensen, {Lisbet A.} and Gitte Pedersen and Jens Kjeldsen and Jacobsen, {Bent A.} and Oxholm, {Anne Sophie} and Jakob Kjellberg and Klaus Bendtzen and Ainsworth, {Mark A.}",
year = "2013",
doi = "10.1016/S0016-5085(13)60074-8",
language = "English",
volume = "144",
pages = "22",
journal = "Gastroenterology",
issn = "0016-5085",
publisher = "Heinemann",
number = "5, Supplement 1",

}

Treatment of Secondary Infliximab Failure in Crohn's Disease Based on Serum Levels of Infliximab and Antibodies Against Infliximab : The Danish Study of Optimizing Infliximab Therapy in Crohn's Disease (Do It Crohn) Randomized Clinical Trial. / Steenholdt, Casper; Brynskov, Jorn; Thomsen, Ole.; Munck, Lars K.; Fallingborg, Jan; Christensen, Lisbet A.; Pedersen, Gitte; Kjeldsen, Jens; Jacobsen, Bent A.; Oxholm, Anne Sophie; Kjellberg, Jakob; Bendtzen, Klaus; Ainsworth, Mark A.

In: Gastroenterology, Vol. 144, No. 5, Supplement 1, 94, 2013, p. 22 .

Research output: Contribution to journalConference abstract in journalResearchpeer-review

TY - ABST

T1 - Treatment of Secondary Infliximab Failure in Crohn's Disease Based on Serum Levels of Infliximab and Antibodies Against Infliximab

T2 - The Danish Study of Optimizing Infliximab Therapy in Crohn's Disease (Do It Crohn) Randomized Clinical Trial

AU - Steenholdt, Casper

AU - Brynskov, Jorn

AU - Thomsen, Ole.

AU - Munck, Lars K.

AU - Fallingborg, Jan

AU - Christensen, Lisbet A.

AU - Pedersen, Gitte

AU - Kjeldsen, Jens

AU - Jacobsen, Bent A.

AU - Oxholm, Anne Sophie

AU - Kjellberg, Jakob

AU - Bendtzen, Klaus

AU - Ainsworth, Mark A.

PY - 2013

Y1 - 2013

U2 - 10.1016/S0016-5085(13)60074-8

DO - 10.1016/S0016-5085(13)60074-8

M3 - Conference abstract in journal

VL - 144

SP - 22

JO - Gastroenterology

JF - Gastroenterology

SN - 0016-5085

IS - 5, Supplement 1

M1 - 94

ER -